Cerenome, Inc. (CNSY)
0.6301
-0.07
(-10.29%)
USD |
NASDAQ |
Nov 20, 16:00
0.6301
0.00 (0.00%)
After-Hours: 20:00
Cerenome Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 29, 2026 | 2.489 |
| September 28, 2026 | 2.703 |
| September 25, 2026 | 2.663 |
| September 24, 2026 | 2.502 |
| September 23, 2026 | 2.609 |
| September 22, 2026 | 2.716 |
| September 21, 2026 | 2.542 |
| September 18, 2026 | 2.716 |
| September 17, 2026 | 2.716 |
| September 16, 2026 | 2.730 |
| September 15, 2026 | 2.837 |
| September 14, 2026 | 2.904 |
| September 11, 2026 | 3.111 |
| September 10, 2026 | 3.198 |
| September 09, 2026 | 3.332 |
| September 08, 2026 | 3.613 |
| September 04, 2026 | 3.686 |
| September 03, 2026 | 3.988 |
| September 02, 2026 | 3.934 |
| September 01, 2026 | 3.626 |
| August 31, 2026 | 3.773 |
| August 28, 2026 | 4.081 |
| August 27, 2026 | 4.148 |
| August 26, 2026 | 4.041 |
| August 25, 2026 | 4.128 |
| Date | Value |
|---|---|
| August 24, 2026 | 3.961 |
| August 21, 2026 | 4.108 |
| August 20, 2026 | 4.014 |
| August 19, 2026 | 4.268 |
| August 18, 2026 | 4.121 |
| August 17, 2026 | 4.282 |
| August 14, 2026 | 4.924 |
| August 13, 2026 | 4.951 |
| August 12, 2026 | 4.951 |
| August 11, 2026 | 5.125 |
| August 10, 2026 | 5.138 |
| August 07, 2026 | 5.125 |
| August 06, 2026 | 5.165 |
| August 05, 2026 | 5.232 |
| August 04, 2026 | 5.299 |
| August 03, 2026 | 4.710 |
| July 31, 2026 | 5.178 |
| July 30, 2026 | 4.884 |
| July 29, 2026 | 4.857 |
| July 28, 2026 | 5.031 |
| July 27, 2026 | 4.991 |
| July 24, 2026 | 5.125 |
| July 23, 2026 | 5.058 |
| July 22, 2026 | 5.112 |
| July 21, 2026 | 5.245 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Alnylam Pharmaceuticals, Inc. | 5.343 |
| Ernexa Therapeutics, Inc. | 0.5143 |
| ACADIA Pharmaceuticals, Inc. | 2.131 |
| Anika Therapeutics, Inc. | 1.288 |
| Savara, Inc. | 8.118 |
Price to Book Value Related Metrics
| PS Ratio | 1.190 |
| Price | 0.6301 |
| Earnings Yield | -718.1% |
| Market Cap | 4.965M |